ReviewJournal of orthopaedic research : official publication of the Orthopaedic Research Society2025
Changes in Glenohumeral Musculoskeletal Development Following Brachial Plexus Birth Injury.
Review in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Brachial plexus birth injury (BPBI), one of the most common nerve injuries in children, often leads to impaired shoulder development, resulting in sustained postural and bone deformity and muscle weakness. Despite the substantial long-term consequences, clinical consensus is lacking for what BPBI treatments are optimal in terms of timing and approach, primarily because BPBI sequelae are complex, involving stunted muscle growth, muscle denervation, and limb disuse that can disrupt glenohumeral joint development. Injury can occur as nerve rupture (postganglionic injury) or nerve avulsion (preganglionic injury), which have distinct musculoskeletal consequences yet are often treated similarly clinically due to their similar initial presentations and the inability of existing methods to distinguish between them. Most of our clinical knowledge about the musculoskeletal detriments in the shoulder comes from studies in nerve rupture patients. Knowledge is generally lacking for the specific effects of injury location on the development and progression of muscle and bone deficits following BPBI. A better understanding of the distinct effects of postganglionic and preganglionic BPBI is important for developing more effective and targeted treatments. More studies are needed to elucidate differences between nerve rupture and nerve avulsion and the particular factors driving glenohumeral deformity development. This paper reviews current knowledge about clinical musculoskeletal deformity development in the shoulder following BPBI, as well as additional insights gleaned from animal and computational models, and identifies key gaps that need to be addressed in future studies to inform better approaches for mitigating and preventing glenohumeral deformity in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.